Form 4: HeartBeam CFO Tim Cruickshank Granted 150,000 Stock Options

HeartBeam's CFO, Tim Cruickshank, was granted 150,000 stock options on April 7, 2025, according to a recent SEC Form 4 filing.

Summary

• Tim Cruickshank, the Chief Financial Officer of HeartBeam, Inc. [BEAT], was granted 150,000 stock options on April 7, 2025.
• The options have an exercise price of $1.65.
• The options vest over a 4-year period, with 25% vesting immediately on April 7, 2025, and the remaining options vesting monthly thereafter.
• The options expire on April 7, 2035.
• Following the transaction, Cruickshank directly owns 550,000 shares of HeartBeam common stock.
• The options were issued under the company's 2022 Equity Incentive Plan.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reports a standard executive compensation practice. The grant of options is generally viewed positively as it aligns management interests with shareholders, but it's a routine event.

Positives

• The granting of stock options to the CFO aligns his interests with those of the shareholders.
• The vesting schedule incentivizes the CFO to remain with the company for the long term.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

Stock option grants are a common practice in the technology and biotech industries to incentivize and retain key executives.

Stakeholder Impact

• Shareholders may view the option grant as a positive sign of aligning management's interests with the company's success.
• Employees may see the option grant as a sign of the company's commitment to its leadership.

Key Dates

Keywords

stock options, Form 4, HeartBeam, Tim Cruickshank, CFO, equity incentive plan, beneficial ownership